Amedeo Smart

Free Medical Literature Service


 

Amedeo

Alzheimer's Disease

  Free Subscription

07.07.2025

14 Alzheimers Dement
1 Am J Geriatr Psychiatry
2 BMC Geriatr
1 BMC Neurol
1 Curr Alzheimer Res
1 Curr Opin Neurol
1 Dement Geriatr Cogn Disord
1 Exp Neurol
19 J Alzheimers Dis
1 J Biol Chem
2 J Neurochem
1 Nat Med
1 Nat Rev Neurol
1 Neurobiol Aging
1 Neurobiol Dis
1 Neurol Clin Pract
1 PLoS Biol
1 PLoS One



    Alzheimers Dement

  1. GEZEGEN H, Alaylioglu M, Sahin E, Swann O, et al
    Unravelling the plasma proteome: Pioneering biomarkers for differential dementia diagnosis.
    Alzheimers Dement. 2025;21:e70162.
    >> Share

  2. LIAO W, Xuan J, Ryu WI, Bormann MK, et al
    Interconnections of insulin/IGF-1 signaling and autophagy abnormalities in Alzheimer's disease.
    Alzheimers Dement. 2025;21:e70099.
    >> Share

  3. FERTAN E, Meisl G, Klenerman D
    Small-diffusible aggregates, plaques, tangles, and dynamic equilibria: Untangling Alzheimer's disease.
    Alzheimers Dement. 2025;21:e70462.
    >> Share

  4. FALGAS N, Maure-Blesa L, Ances B, Flores-Aguilar L, et al
    Genetically determined Alzheimer's disease research advances: The Down Syndrome & Autosomal Dominant Alzheimer's Disease 2024 Conference.
    Alzheimers Dement. 2025;21:e70309.
    >> Share

  5. RUDOLPH MD, Sutphen CL, Register TC, Lockhart SN, et al
    Evaluation of plasma p-tau217 for detecting amyloid pathology in a heterogeneous community-based cohort.
    Alzheimers Dement. 2025;21:e70426.
    >> Share

  6. BROWN CA, Das SR, Cousins KAQ, Tropea TF, et al
    Tau burden is best captured by magnitude and extent: Tau-MaX as a measure of global tau.
    Alzheimers Dement. 2025;21:e70346.
    >> Share

  7. KANG JW, Khatib LA, Heston MB, Dilmore AH, et al
    Gut microbiome compositional and functional features associate with Alzheimer's disease pathology.
    Alzheimers Dement. 2025;21:e70417.
    >> Share

  8. GIMENEZ S, Vaque-Alcazar L, Zhu N, Benejam B, et al
    Impact of Alzheimer's disease on sleep in adults with Down syndrome.
    Alzheimers Dement. 2025;21:e70400.
    >> Share

  9. LEMING M, Im H
    Differential dementia detection from multimodal brain images in a real-world dataset.
    Alzheimers Dement. 2025;21:e70362.
    >> Share

  10. KEMNA RE, Kueck PJ, Honea R, Clark Z, et al
    Mitochondrial DNA affects tau phosphorylation in aging and Alzheimer's disease.
    Alzheimers Dement. 2025;21:e70390.
    >> Share

  11. GALGANI A, Mary A, Lombardo F, Martini N, et al
    Locus coeruleus integrity correlates with plasma soluble Axl levels in Alzheimer's disease patients.
    Alzheimers Dement. 2025;21:e70434.
    >> Share

  12. CARRIGAN M, Bocancea DI, Vogel J, van Loenhoud AC, et al
    A novel approach to resilience and its links with education and Alzheimer's disease genetics.
    Alzheimers Dement. 2025;21:e70379.
    >> Share

  13. FU JF, Garimella A, Lapointe A, Aye WWT, et al
    Joint spatial associations of amyloid beta and tau pathology in Down syndrome and preclinical Alzheimer's disease: Cross-sectional associations with early cognitive impairments.
    Alzheimers Dement. 2025;21:e70424.
    >> Share

  14. MALOTAUX V, Ashton NJ, Ohrfelt A, Chen Y, et al
    Plasma p-tau231 in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: A cross-sectional and longitudinal cohort study.
    Alzheimers Dement. 2025;21:e70421.
    >> Share


    Am J Geriatr Psychiatry

  15. BONAR EE, Tan CY, Patyk A, Lei L, et al
    Agitation in Alzheimer's Disease as a Qualifying Condition for Medical Cannabis in the United States: A Brief Report on Current Trends.
    Am J Geriatr Psychiatry. 2025 Jun 11:S1064-7481(25)00363.
    >> Share


    BMC Geriatr

  16. MORGELI R, Borchers F, Feinkohl I, Piper SK, et al
    A secondary analysis of cortical atrophy and plasma amyloid beta patterns in older patients with cognitive frailty undergoing elective surgery.
    BMC Geriatr. 2025;25:484.
    >> Share

  17. SU H, Zhu J, Wang Y, Jin J, et al
    Reliability and validity analysis of the Chinese version of the Quick Dementia Rating System (QDRS).
    BMC Geriatr. 2025;25:455.
    >> Share


    BMC Neurol

  18. LONG Y, Liu J, Guo J, Jiang J, et al
    Integrated genetic analysis of Alzheimer's disease and stroke subtypes: insights from LDSC, PLACO, and MR studies.
    BMC Neurol. 2025;25:260.
    >> Share


    Curr Alzheimer Res

  19. PLUTA R, Kocki J, Kocka AB, Bogucki J, et al
    Alterations of Mitophagy (BNIP3), Apoptosis (CASP3), and Autophagy (BECN1) Genes in the Frontal Cortex in an Ischemic Model of Alzheimer's Disease with Long-Term Survival.
    Curr Alzheimer Res. 2025 Jul 2. doi: 10.2174/0115672050385480250619045022.
    >> Share


    Curr Opin Neurol

  20. PAPOULI A, Cole JH
    Brain age prediction from MRI scans in neurodegenerative diseases.
    Curr Opin Neurol. 2025;38:316-321.
    >> Share


    Dement Geriatr Cogn Disord

  21. SEIXAS-LIMA B, Binns M, Black SE, Freedman M, et al
    The relationship between age and cognitive subtypes of Alzheimer's disease and related dementias.
    Dement Geriatr Cogn Disord. 2025 Jun 30:1-19. doi: 10.1159/000547124.
    >> Share


    Exp Neurol

  22. FRENCH AR, Christian-Hinman CA
    Aromatase inhibition modulates intrinsic properties and excitability of hippocampal CA1 pyramidal cells in the APP/PS1 mouse model of Alzheimer's disease.
    Exp Neurol. 2025 Jun 30:115365. doi: 10.1016/j.expneurol.2025.115365.
    >> Share


    J Alzheimers Dis

  23. LIU J, Duangjan C, Phan NM, Curran SP, et al
    Loss of WDR23 slows the rate of age-related cognitive decline with elevated amyloid burden.
    J Alzheimers Dis. 2025;106:218-229.
    >> Share

  24. CAI Y, Wang X, Xiang Y, Wang Z, et al
    Codonopsis pilosula polysaccharides alleviate neuronal apoptosis induced by endoplasmic reticulum stress-activated PERK-ATF4-CHOP signaling in APP/PS1 mice.
    J Alzheimers Dis. 2025;106:317-330.
    >> Share

  25. ZHAI A, Zou R, Lv T, Yang S, et al
    Genetic association of social participation with cognitive function: A bidirectional Mendelian randomization study.
    J Alzheimers Dis. 2025;106:259-270.
    >> Share

  26. ANDERSEN LSN, Simonsen AH, Vogel A, McWilliam OH, et al
    Isolated elevation of 181p-tau in the cerebrospinal fluid is associated with distinct clinical features: Findings from a Danish memory clinic cohort.
    J Alzheimers Dis. 2025;106:111-119.
    >> Share

  27. SEKIKAWA A, Higashiyama A, Lopresti BJ, Ihara M, et al
    An inverse association of cerebral amyloid-beta deposition and serum docosahexaenoic acid levels in cognitively normal older adults in Japan.
    J Alzheimers Dis. 2025;106:378-386.
    >> Share

  28. YIN A, Gui Y, Wan L, Cai Q, et al
    p53 SUMOylation promotes neurogenesis defects in APP/PS1 mice.
    J Alzheimers Dis. 2025;106:352-362.
    >> Share

  29. HOILUND-CARLSEN PF, Alavi A, Costa T, Neve RL, et al
    Is US residence a risk factor for Alzheimer's disease?
    J Alzheimers Dis. 2025 Jul 3:13872877251356682. doi: 10.1177/13872877251356682.
    >> Share

  30. PALEY JL, Scheiffele GD, Li Y, Shaaban CE, et al
    Neighborhood deprivation and mortality among people with Alzheimer's disease and related dementia.
    J Alzheimers Dis. 2025 Jul 2:13872877251352120. doi: 10.1177/13872877251352120.
    >> Share

  31. HSU YH, Huang SM, Kuo LW, Yang JJ, et al
    Diagnostic utility of the item-specific Encoding Deficit Index in relation to medial temporal lobe atrophy in early-stage Alzheimer's disease.
    J Alzheimers Dis. 2025 Jul 2:13872877251351612. doi: 10.1177/13872877251351612.
    >> Share

  32. BOSE C, Hindle A, Smith SC, Strickland J, et al
    Low-dose dietary vorinostat increases brain histone acetylation levels and reduces oxidative stress in an Alzheimer's disease mouse model.
    J Alzheimers Dis. 2025 Jul 1:13872877251352107. doi: 10.1177/13872877251352107.
    >> Share

  33. WALCZAK K, Kolodziejczyk W, Pszczolowska M, Kozlowska M, et al
    Klotho protein in Alzheimer's disease: Diet leading to immortality?
    J Alzheimers Dis. 2025 Jul 1:13872877251350125. doi: 10.1177/13872877251350125.
    >> Share

  34. LIU SK, Cao H, Yang X, Zhou X, et al
    An ABCA1 missense variant decreases cholesterol efflux and confers Alzheimer's disease risk in the Chinese population.
    J Alzheimers Dis. 2025 Jul 1:13872877251350722. doi: 10.1177/13872877251350722.
    >> Share

  35. SARAIVA JA, Becker M, Dyrba M, Bolukbas B, et al
    Electroencephalogram features support the retrogenesis hypothesis of Alzheimer's disease: Exploratory comparison of brain changes in aging and childhood.
    J Alzheimers Dis. 2025 Jun 30:13872877251352119. doi: 10.1177/13872877251352119.
    >> Share

  36. SATO K, Niimi Y, Ihara R, Iwata A, et al
    Effect of corrections for renal function on plasma phosphorylated tau performance for Alzheimer's disease.
    J Alzheimers Dis. 2025 Jun 30:13872877251350718. doi: 10.1177/13872877251350718.
    >> Share

  37. WANG G, Chen T, O'Gorman J, Li Y, et al
    Harnessing greater statistical power: Comprehensive evaluation of disease modifying treatment effects across all or multiple post-baseline visits compared to the last visit for Alzheimer's disease clinical trials.
    J Alzheimers Dis. 2025 Jun 30:13872877251352189. doi: 10.1177/13872877251352189.
    >> Share

  38. SHANG ZT, Huang XY, Xiong LL, Xu ZC, et al
    Methanol extract from miracle fruit seeds mitigates Alzheimer's disease and enhance autophagy via suppressing the AKT/mTOR signal pathway.
    J Alzheimers Dis. 2025 Jun 30:13872877251352545. doi: 10.1177/13872877251352545.
    >> Share

  39. ESLICK S, Austin G, Ferguson JJ, Garg ML, et al
    Blood biomarkers of Alzheimer's disease in Australians habitually consuming various plant-based diets.
    J Alzheimers Dis. 2025 Jun 30:13872877251351549. doi: 10.1177/13872877251351549.
    >> Share

  40. RICCHI I, Griffa A, Corredor-Jerez R, Richiardi J, et al
    The complementary role of automated brain volumetry to stratify ADNI participants within the ATN framework.
    J Alzheimers Dis. 2025;106:245-258.
    >> Share

  41. LOJO-RAMIREZ JA, Fernandez-Rodriguez P, Guerra-Gomez M, Marin-Cabanas AM, et al
    Evaluation of early-phase (18)F-Florbetaben PET as a surrogate biomarker of neurodegeneration: In-depth comparison with (18)F-FDG PET at group and single patient level.
    J Alzheimers Dis. 2025;106:304-316.
    >> Share


    J Biol Chem

  42. KURKELA M, Dvorakova L, Koivisto H, Uusitalo M, et al
    Targeting HIF-P4H-2 in APP/PS1 Alzheimer's mouse model improves glucose metabolism, reduces dystrophic neurites and maintains exploratory activity.
    J Biol Chem. 2025 Jul 1:110432. doi: 10.1016/j.jbc.2025.110432.
    >> Share


    J Neurochem

  43. CHEN Y, Albert AL, Sehrawat A, Farinas MF, et al
    Equivalence of Plasma and Serum for Clinical Measurement of p-tau217: Comparative Analyses of Four Blood-Based Assays.
    J Neurochem. 2025;169:e70114.
    >> Share

  44. HARDY J
    Milestone Review: The History of Molecular Genetics Analysis of Alzheimer's Disease.
    J Neurochem. 2025;169:e70148.
    >> Share


    Nat Med

  45. COLONNA M, Holtzman DM
    Rethinking TREM2 as a target for Alzheimer's disease after the INVOKE-2 trial failure.
    Nat Med. 2025 Jul 2. doi: 10.1038/s41591-025-03816.
    >> Share


    Nat Rev Neurol

  46. TADDEI RN, Duff KE
    Synapse vulnerability and resilience across the clinical spectrum of dementias.
    Nat Rev Neurol. 2025;21:353-369.
    >> Share


    Neurobiol Aging

  47. AKRADI M, Farzane-Daghigh T, Ebneabbasi A, Bi H, et al
    How is self-reported sleep-disordered breathing linked with biomarkers of Alzheimer's disease?
    Neurobiol Aging. 2025;154:16-24.
    >> Share


    Neurobiol Dis

  48. PELAGOTTI V, Plantone D, D'Amico F, Raffa S, et al
    [(18)F]FDG PET metabolic correlates of cerebrospinal fluid TAR DNA-binding protein 43 in prodromal Alzheimer's disease.
    Neurobiol Dis. 2025 Jul 1:107014. doi: 10.1016/j.nbd.2025.107014.
    >> Share


    Neurol Clin Pract

  49. SCHWARTZ NU, Dietz CD, Prufer Araujo I, Villanueva-Meyer JE, et al
    Changes of a Cerebral Cavernous Malformation Associated With Lecanemab Therapy in a Patient With Alzheimer Disease.
    Neurol Clin Pract. 2025;15:e200508.
    >> Share


    PLoS Biol

  50. CHEN S, Zhou J, Wang S, Chen E, et al
    Gnb5 is a negative regulator of the BACE1-mediated Abeta generation and ameliorates cognitive deficits in a mouse model of Alzheimer's disease.
    PLoS Biol. 2025;23:e3003259.
    >> Share


    PLoS One

  51. ZHANG J, Huang Y, Jiang Y, Li T, et al
    Knowledge and attitudes towards Alzheimer's disease among adult residents in Jiulongpo, Chongqing, China: A cross-sectional survey.
    PLoS One. 2025;20:e0327346.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016